Defining treatment margins for six field conformal irradiation of localized prostate cancer

International Journal of Radiation Oncology, Biology, Physics

Volumn 28, Issue 1, 1994, Pages 267-275

  Roach III, Mack ^a   Pickett, Barby ^a   Rosenthal, Seth A ^b   Verhey, Lynn ^a   Phillips, Theodore L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 D conformal radiotherapy; Prostate irradiation

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; IRRADIATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TUMOR VOLUME;

HUMAN; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY;

EID: 0028009216     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)90167-8     Document Type: Article

References (40)

1. Radiotherapy for prostate cancer: Should the seminal vesicles be considered target?
2. Current conflicts in the management of prostate cancer
3. Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations.
4. Indications for and the significance of seminal vesicle irradiation during 3-D conformal therapy for localized prostate cancer
5. Dose-volume histograms
6. Carcinoma of the prostate: Results of postirradiation biopsy
7. Calculation of the uncertainty in dose delivered during radiation therapy
8. Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease
9. Quality control of radiation therapy in multi-institutional randomized clinical trial for localized prostate cancer
10. Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen
11. The value of extended field radiation therapy in carcinoma of the prostate
12. Stage A versus Stage B adenocarcinoma of the prostate: Morphological comparison and biological significance
13. Latent residual tumor following external radiotherapy for prostate cancer
14. The use of prostate specific antigen (PSA) and Gleason score to predict the pathologic stage in men with localized prostate cancer (Abstract 700)
15. Carcinoma of the prostate
16. Correlation of radiotherapeutic parameters and treatment related morbidity: Analysis of RTOG Study 7706
17. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate-Analysis of RTOG 75-06
18. Computed tomography in definitive radiotherapy of prostatic carcinoma, Part 2: Definition of target volume
19. Retrograde urographic technique in the radiotherapy treatment planning of prostate cancer
20. Accuracy of radiation field alignment in clinical practice
21. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer
22. Predicting the risk of lymph node involvement using the pretreatment PSA and Gleason score in men with clinically localized prostate cancer
23. The role of the urethragram during simulation for localized prostate cancer
24. An analysis of the advantages as well as the physical and clinical limitations of three-dimensionally (3-D) based co-planar conformal external beam irradiation (XRT) in the treatment of localized prostate cancer (Abstract
25. Local failure after definitive therapy for prostate cancer
26. Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate cancer
27. Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of postirradiation prostate biopsy
28. Prostate cancer: Retrograde urethrography to improve treatment planning for radiation therapy
29. Three-dimensional treatment planning considerations for prostate cancer
30. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose
31. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
32. Positive surgical margins at radical prostatectomy: Importance of the apical dissection
33. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder
34. Boost treatment of the prostate using shaped, fixed fields
35. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma
36. The role of perineural space invasion in the local spread of prostatic adenocarcinoma
37. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate
38. Beams eye view based photon radiotherapy